Lunch Innovation Theater (Non-Accredited): Treating MDD: A Rapid-Acting Oral Antidepressant with Multimodal Activity

Lunch will be served. Seating is limited to 150 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):
Kristian Dambrino, PMHNP-BC; Brooke Kempf, PMHNP-BC; Mecca, Patient Ambassador

This presentation is provided by Axsome Therapeutics, Inc.